Where does Vincent Miles work?

Vincent Miles is Partner at Abingworth.

What does Vincent Miles invest in?

Vincent Miles invests in Biotech.

What check size does Vincent Miles write?

Vincent Miles typically writes checks of $15M – $30M.

Where did Vincent Miles go to school?

Vincent Miles studied at UCL (B.Sc. (biochemistry), Ph.D. (biochemical embryology/molecular biology)).

Vincent Miles

Investor

Partner at Abingworth

Boston, Massachusetts

Writes $15M – $30M checks · typically $22.5M

About

Vincent Miles is an Executive Director at Abingworth, which he joined in 2007, where he helps identify and evaluate new business opportunities and supports portfolio companies. He previously served as Senior Vice President of Business Development at Alnylam Pharmaceuticals and held VP roles at Millennium Pharmaceuticals, and earlier led the technology transfer office at the Dana-Farber Cancer Institute and held positions at RiboGene, Pharmacia, and Amersham International. He holds a BSc in Biochemistry and a PhD in Biochemical Embryology from University College London.

Contact· self-published, not guessed

m•••@abingworth.comreveal

Invests in

Biotech

Experience

AbingworthExecutive Directorcurrent2022 — presentGreater Boston
AbingworthPartner2007 — 2022Boston, Massachusetts, United States
Alnylam PharmaceuticalsSenior VP, Business Development2003 — 2007
Millennium PharmaceuticalsVP, Business Development, Technology Management1997 — 2003
Dana Farber Cancer InstituteDirector, Office of Technology Transfer1996 — 1997
RiboGene (a predecessor of Questcor)VP, R&D and Business Development1992 — 1996
Pharmacia BiotechVP, International Marketing (Molecular Biology Division)1989 — 1992
Pharmacia BiotechVP, R&D (Molecular Biology Division)1986 — 1990
Amersham InternationalR&D and Business Development1978 — 1986
Home Office Forensic Science LaboratoryHigher Scientific Officer1975 — 1978

Skills & more

Strategic Planning3Strategy4Management1R&D23Business Development22Commercialization8Technology Transfer27Start-ups7Biology2Licensing5Corporate Development8Competitive Analysis3

+12 more

Venture CapitalMergersLifesciencesBiotechnologyDue DiligenceEntrepreneurshipPharmaceutical IndustryOncologyBusiness PlanningBusiness StrategyMergers & AcquisitionsDrug Development

From Vincent's professional profile.

Investments

Board seats

Atsena TherapeuticsBrave BioChiasmaDicerna PharmaceuticalsDynex TechnologiesHydra BiosciencesIFM DueIFM TherapeuticsIFM TreMagellan DiagnosticsNido BiosciencesPersonalisPrimeraDx

Per the firm's website.

Colleagues at Abingworth

Alex Asquith

Counsel at Abingworth

Amit Khasgiwala

Investment Professional at Innovatus Capital Partners

Andrew Sinclair

Managing Director, Head of Publics & Late Stage at Abingworth

Ankur Shah

Vice President, CCD at Abingworth

Anna Slezak

Senior Associate at Abingworth

Bali Muralidhar

Global Head of Life Sciences & CIO at Abingworth

Carlos Paya

Venture Partner at Ysios Capital

Dayle Hogg

Operating Executive at Abingworth

Frequently asked questions

Who is Vincent Miles?: Vincent Miles is an Executive Director at Abingworth, which he joined in 2007, where he helps identify and evaluate new business opportunities and supports portfolio companies. He previously served as Senior Vice President of Business Development at Alnylam Pharmaceuticals and held VP roles at Millennium Pharmaceuticals, and earlier led the technology transfer office at the Dana-Farber Cancer Institute and held positions at RiboGene, Pharmacia, and Amersham International. He holds a BSc in Biochemistry and a PhD in Biochemical Embryology from University College London.
Where does Vincent Miles work?: Vincent Miles is Partner at Abingworth.
What does Vincent Miles invest in?: Vincent Miles invests in Biotech.
What check size does Vincent Miles write?: Vincent Miles typically writes checks of $15M – $30M.
What boards does Vincent Miles sit on?: Vincent Miles holds tracked board seats at Atsena Therapeutics, Brave Bio, Chiasma, Dicerna Pharmaceuticals, Dynex Technologies, Hydra Biosciences, IFM Due, IFM Therapeutics, IFM Tre, Magellan Diagnostics.
Where did Vincent Miles go to school?: Vincent Miles studied at UCL (B.Sc. (biochemistry), Ph.D. (biochemical embryology/molecular biology)).